<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01447160</url>
  </required_header>
  <id_info>
    <org_study_id>FUSao Paulo</org_study_id>
    <nct_id>NCT01447160</nct_id>
  </id_info>
  <brief_title>Effectiveness of Facet Joint Infiltration in Low Back Pain</brief_title>
  <official_title>Effectiveness of Facet Joint Infiltration in Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federal University of São Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federal University of São Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effectiveness of facet joint infiltration with
      corticosteroids in the treatment of low back pain due to facet joint osteoarthritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sixty subjects with diagnostic of facet joint syndrome will be enrolled in the study.

      They were randomized into experimental and control groups. The experimental group will be
      submitted to intra-articular infiltration of six facet joints. The control group will be
      submitted to intramuscular injection of six lumbar paravertebral points. After the
      randomization, all subjects will be assessed by an investigator blinded to the groups. The
      assessment will be taken just before the interventions (T0) and them 7 , 30 , 90 and 180 days
      after the interventions. The following assessment instruments will be used: pain visual
      analogical scale (VAS) (0-10cm), pain visual analogical scale during extension of the spine
      (VAS E) (0-10cm), Likert scale for improving (0-5), percentage scale of subjective improving
      perception(0-100%), Rolland-Morris questionnaire (0-24), short health survey questionnaire
      (SF36), accountability of medications taken for back pain: analgesics and non-steroidal
      antiinflammatories (NSAIDs).
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">April 2012</completion_date>
  <primary_completion_date type="Anticipated">April 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>baseline</time_frame>
    <description>pain visual scale graduated from zero to ten</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>4 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>12 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain visual analogic scale</measure>
    <time_frame>24 weeks</time_frame>
    <description>pain visual analogic scale graduated 0--10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>baseline</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>12 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rolland Morris questionnaire</measure>
    <time_frame>24 weeks</time_frame>
    <description>assess functional capacity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>baseline</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>12 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionnaire</measure>
    <time_frame>24 weeks</time_frame>
    <description>assess quality of life</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>facet joint infiltration</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will be submitted to intra-articular infiltration of six facet joints (L3/L4;L4/L5;L5/S1 bilaterally) with triamcinolone hexacetonide</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intramuscular injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group which were submitted to triamcinolone acetonide intramuscular injection of six lumbar paravertebral points</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Cortisone</intervention_name>
    <description>intraarticular infiltration with 1ml of triamcinolone hexacetonide versus intramuscular injection with 1 ml of triamcinolone acetonide</description>
    <arm_group_label>facet joint infiltration</arm_group_label>
    <arm_group_label>intramuscular injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  low back pain up to 3 months

          -  pain on back extension

          -  radiologic findings of facet joint osteoarthritis

        Exclusion Criteria:

          -  other causes of back pain

          -  fibromyalgia

          -  diabetes, arterial hypertension or glaucoma not well controlled

          -  patients with contrast allergy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Luiza Ribeiro, doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sao Paulo Federal University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>luiza ribeiro, doctor</last_name>
    <phone>55-11 92678027</phone>
    <email>luizahcr@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sao Paulo federal University</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>04023-062</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Luiza Ribeiro, doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 29, 2011</study_first_submitted>
  <study_first_submitted_qc>October 5, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2011</study_first_posted>
  <last_update_submitted>October 5, 2011</last_update_submitted>
  <last_update_submitted_qc>October 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Federal University os Sao Paulo</name_title>
    <organization>Federal University of São Paulo</organization>
  </responsible_party>
  <keyword>facet joint</keyword>
  <keyword>back pain</keyword>
  <keyword>osteoarthritis</keyword>
  <keyword>infiltration</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Triamcinolone hexacetonide</mesh_term>
    <mesh_term>Triamcinolone</mesh_term>
    <mesh_term>Triamcinolone Acetonide</mesh_term>
    <mesh_term>Cortisone</mesh_term>
    <mesh_term>Triamcinolone diacetate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

